Sufentanil Tablet 30 mcg + Placebo Tablet
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-Operative Pain
Conditions
Post-Operative Pain
Trial Timeline
Feb 1, 2015 → Aug 1, 2015
NCT ID
NCT02356588About Sufentanil Tablet 30 mcg + Placebo Tablet
Sufentanil Tablet 30 mcg + Placebo Tablet is a phase 3 stage product being developed by Talphera for Post-Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02356588. Target conditions include Post-Operative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02356588 | Phase 3 | Completed |
Competing Products
18 competing products in Post-Operative Pain